openPR Logo
Press release

Dystrophin Market to Reach USD 13.02 Billion By 2026 | Top Vendors: Solid Biosciences Inc, Catabasis Pharmaceuticals, Sarepta Therapeutics, Editas Medicine Inc, BioMarin Pharmaceutical Inc

03-20-2019 01:12 PM CET | Health & Medicine

Press release from: Reports and Data

Dystrophin Market

Dystrophin Market

According to the current analysis of Reports and Data, the global Dystrophin Market was valued at 0.60 billion in 2018 and is expected to reach USD 13.02 billion by year 2026, at a CAGR of 47% percent. The growth of the dystrophin market is more in countries such as U.S, Austria, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Norway, Portugal, Slovakia, South Korea, and the United Kingdom; where key muscular dystrophy drugs are available in the market.

The market is characterized by the entry of a large number of players that includes emerging companies, as well as healthcare giants. The primary factor, for the focus of market players, is the unaddressed demand for treatment of muscular dystrophy diseases for a long time. There are over 35 companies engaged in clinical trials for the launch of novel therapeutics for the treatment of DMD. However, owing to stringent regulation across the globe for drug approval, very few drug candidates have received approval by medicine regulatory bodies such as the US Food and Drug Administration (FDA), and European Commission.

Request for PDF Sample at: https://www.reportsanddata.com/sample-enquiry-form/1063

North America is expected to have a high demand on account of the product launches in the U.S. In 2017, North America dominated the dystrophin market in 2017, with a market share of 52.6; followed by Europe. The North America dystrophin market is estimated to be worth USD 45.6 billion by 2025. Factors such as high incidence of muscular dystrophy in the region, accelerated FDA approval of drug in the region, favorable funding scenario for research & development in field of DMD, high healthcare expenditure potential among the North American population, availability of medical reimbursement in the region are among key factors supporting the growth of dystrophin market in North America.

Further key findings from the report suggest
Exon Skipping accounted for 45.3% of the overall industry in 2017 and will witness high growth owing to anticipated adoption across the globe after regulatory approval in Europe and other parts of the world. However, low awareness about therapeutics in developing nations is expected to hamper its growth over the forecast period.

Emerging approaches for muscular dystrophy therapies is expected to witness significant rise at a CAGR of ~90% from 2016 to 2025 in light of favorable inclination of the industry as well as healthcare professionals towards the development of new therapies.

Asia Pacific market was valued at USD 14.1 million in 2017 and is expected to reflect significant growth during the forecast period owing it to anticipated drug launches in the region. Favorable scenario for research and development funds and the presence of various emerging players in the region is likely to promote market growth over the forecast period. As of 2017, there is a lack of well-established effective muscular dystrophy therapy in the region, which is a significant factor for the low market share of the region.

Key participants include PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis Pharmaceuticals among others. PTC Therapeutics has a market presence through its muscular dystrophy drugs under the brand name, Emflaza, and Translarna. As of 2017, PTC Therapeutics dominated the market followed by Sarepta Therapeutics.

Read more at: https://www.reportsanddata.com/report-detail/dystrophin-market

For this report, Reports and Data have segmented the global dystrophin market on the basis of product, approach, and region:

Product Outlook (Revenue, USD Million, 2016 - 2026)
Exondys51
Translarna
Emflaza
Others

Approach Outlook (Revenue, USD Million, 2016 - 2026)
Exon Skipping
Anti-Inflammatory Therapy
Stop Codon Read-Through
Others Approaches

Regional Outlook (Revenue, USD Million, 2016 - 2025)
North America
U.S.
Canada

Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe

Asia Pacific
China
Japan
India
Rest of Asia-Pacific

Rest of the World

Make an enqurie at: https://www.reportsanddata.com/make-enquiry-form/1063

We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.

40 Wall St. 28th floor New York City, NY 10005 United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dystrophin Market to Reach USD 13.02 Billion By 2026 | Top Vendors: Solid Biosciences Inc, Catabasis Pharmaceuticals, Sarepta Therapeutics, Editas Medicine Inc, BioMarin Pharmaceutical Inc here

News-ID: 1664755 • Views: 346

More Releases from Reports and Data

Deep Brain Stimulation Devices Market Size, Company Revenue Share, Key Drivers & …
The global deep brain stimulation devices market size is expected to reach USD 2.48 Billion in 2028 and register a CAGR of 10.2% over the forecast period, according to the latest report by Reports and Data. Rising incidence rate of neurological disorders, rapidly aging population, and increasing advancements in imaging technologies are some key factors expected to drive market revenue growth over the forecast period. Recent advancements in neuroimaging has significantly improved Deep
Electric Intercity Bus Market Recent Technological Advancements to Propel Growth …
The Global Electric Intercity Bus Market Research report published by Reports and Data encompasses vial information and insights of the Electric Intercity Bus market during the forecast period. It covers data on leading segments such as types, applications, regions, technology, and major players involved in the industry. The report offers details about the major technological breakthroughs, product developments, expansion, key strategic ventures, and other vital advancements in the. The report also covers
Textile Films Market Trends, Revenue, Major Players, Share Analysis & Forecast T …
The global textile films market is forecast to reach USD 8,518.1 Million by 2028, according to a new report by Reports and Data. The market growth is attributed to a combination of various market factors. One of the mentionable factors in this regards are changing preference among end-users and raising awareness & demand for eco-friendly products. This changing preference among end-users have increased the demand for Polyurethane (PU) based films
Styrene Market Revenue, Product Launches, Regional Share Analysis & Forecast Til …
A comprehensive report on the Global Styrene Market has been published by Reports and Data that offers insightful data about market dynamics, drivers, restraints, current and emerging trends, market size, market share, and revenue growth of the market. The report provides a brief overview of the industry and gives an estimation of growth and revenue for the forecast period of 2021-2028. The global Styrene market is expected to be valued

All 5 Releases


More Releases for USD

$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Radiopharmaceuticals Market USD 350 Million by 2020
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report https://www.ihealthcareanalyst.com/report/radiopharmaceuticals-market/ Medicinal radiocompounds or radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity and they can be used as diagnostic and therapeutic agents. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone